Transport of monoamine transmitters by the organic cation transporter type 2, OCT2

被引:121
作者
Gründemann, D [1 ]
Köster, S [1 ]
Kiefer, N [1 ]
Breidert, T [1 ]
Engelhardt, M [1 ]
Spitzenberger, F [1 ]
Obermüller, N [1 ]
Schömig, E [1 ]
机构
[1] Univ Heidelberg, Dept Pharmacol, D-69120 Heidelberg, Germany
关键词
D O I
10.1074/jbc.273.47.30915
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recently cloned apical renal transport system for organic cations (OCT2) exists in dopamine-rich tissues such as kidney and some brain areas (Grundemann, D., Babin-Ebell, J., Martel, F., Ording, N., Schmidt, A., and Schomig, E. (1997) J. Biol. Chem. 272, 10408-10413). The study at hand was performed to answer the question of whether OCT2 accepts dopamine and other monoamine transmitters as substrate. 293 cells were stably transfected with the OCT2r cDNA resulting in the 293(OCT2r) cell line. Expression of OCT2r in 293 cells induces specific transport of tritiated dopamine, noradrenaline, adrenaline, and B-hydroxytryptamine (5-HT). Initial rates of specific H-3-dopamine, H-3-noradrenaline, H-3-adrenaline, and H-3-5-HT transport were saturable, the K-m values being 2.1, 4.4, 1.9, and 3.6 mmol/liter. The corresponding V-max values were 3.9, 1.0, 0.59, and 2.5 nmol min(-1).mg of protein(-1), respectively. 1,1'-diisopropyl-2,4'-cyanine (disprocynium24), a known inhibitor of OCT2 with a potent eukaliuric diuretic activity, inhibited SH-dopamine uptake into 293(OCT2r) cells with an K-i of 5.1 (2.6, 9.9) nmol/liter. In situ hybridization reveals that, within the kidney, the OCT2r mRNA is restricted to the outer medulla and deep portions of the medullary rays indicating selective expression in the S3 segment of the proximal tubule. These findings open the possibility that OCT2r plays a role in renal dopamine handling.
引用
收藏
页码:30915 / 30920
页数:6
相关论文
共 28 条
[1]   NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[2]  
[Anonymous], 1989, SYSTAT SYSTEM STAT
[3]  
Aperia A, 1994, Curr Opin Nephrol Hypertens, V3, P39, DOI 10.1097/00041552-199401000-00005
[4]   Neurotransmitter transporters: Molecular biology, function, and regulation [J].
Borowsky, B ;
Hoffman, BJ .
INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 38, 1995, 38 :139-199
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]  
Eisenhofer G, 1996, N-S ARCH PHARMACOL, V354, P287
[8]  
GIROS B, 1992, MOL PHARMACOL, V42, P383
[9]  
GOLDSTEIN M, 1972, PHARMACOL REV, V24, P293
[10]   Cloning and characterization of two human polyspecific organic cation transporters [J].
Gorboulev, V ;
Ulzheimer, JC ;
Akhoundova, A ;
UlzheimerTeuber, I ;
Karbach, U ;
Quester, S ;
Baumann, C ;
Lang, F ;
Busch, AE ;
Koepsell, H .
DNA AND CELL BIOLOGY, 1997, 16 (07) :871-881